757 related articles for article (PubMed ID: 17370251)
1. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro.
Worek F; Aurbek N; Thiermann H
J Appl Toxicol; 2007; 27(6):582-8. PubMed ID: 17370251
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics.
Worek F; Koller M; Thiermann H; Wille T
Toxicology; 2016 Mar; 350-352():25-30. PubMed ID: 27153754
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
[TBL] [Abstract][Full Text] [Related]
4. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates.
Worek F; Reiter G; Eyer P; Szinicz L
Arch Toxicol; 2002 Sep; 76(9):523-9. PubMed ID: 12242610
[TBL] [Abstract][Full Text] [Related]
5. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
[TBL] [Abstract][Full Text] [Related]
6. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds.
Worek F; Widmann R; Knopff O; Szinicz L
Arch Toxicol; 1998 Mar; 72(4):237-43. PubMed ID: 9587020
[TBL] [Abstract][Full Text] [Related]
7. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
Maxwell DM; Brecht KM; Sweeney RE
Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
[TBL] [Abstract][Full Text] [Related]
9. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
[TBL] [Abstract][Full Text] [Related]
10. A structure-activity analysis of the variation in oxime efficacy against nerve agents.
Maxwell DM; Koplovitz I; Worek F; Sweeney RE
Toxicol Appl Pharmacol; 2008 Sep; 231(2):157-64. PubMed ID: 18508103
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of sarin-inhibited pig brain acetylcholinesterase using oxime antidotes.
Kuca K; Jun D
J Med Toxicol; 2006 Dec; 2(4):141-6. PubMed ID: 18072133
[TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
[TBL] [Abstract][Full Text] [Related]
13. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
Kassa J; Jun D; Kuca K
J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
[TBL] [Abstract][Full Text] [Related]
14. Pseudocatalytic scavenging of the nerve agent VX with human blood components and the oximes obidoxime and HI-6.
Wille T; von der Wellen J; Thiermann H; Worek F
Arch Toxicol; 2017 Mar; 91(3):1309-1318. PubMed ID: 27358236
[TBL] [Abstract][Full Text] [Related]
15. Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase.
Worek F; von der Wellen J; Musilek K; Kuca K; Thiermann H
Arch Toxicol; 2012 Sep; 86(9):1379-86. PubMed ID: 22437842
[TBL] [Abstract][Full Text] [Related]
16. In vitro reactivation of acetylcholinesterase using the oxime K027.
Kuca K; Kassa J
Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
[TBL] [Abstract][Full Text] [Related]
17. Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro.
Kuca K; Jun D; Bajgar J
Drug Chem Toxicol; 2007; 30(1):31-40. PubMed ID: 17364862
[TBL] [Abstract][Full Text] [Related]
18. Oxime-mediated in vitro reactivation kinetic analysis of organophosphates-inhibited human and electric eel acetylcholinesterase.
Sahu AK; Sharma R; Gupta B; Musilek K; Kuca K; Acharya J; Ghosh KK
Toxicol Mech Methods; 2016 Jun; 26(5):319-26. PubMed ID: 27101948
[TBL] [Abstract][Full Text] [Related]
19. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques.
Bajgar J; Hajek P; Zdarova JK; Kassa J; Paseka A; Slizova D; Krs O; Kuca K; Jun D; Fusek J; Capek L
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):790-7. PubMed ID: 21054236
[TBL] [Abstract][Full Text] [Related]
20. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
